1 min read

From S.L.E. to Teva: The Industry's Early History

Teva traces its origins to S.L.E., a Jerusalem medicine distributor founded in 1901. The modern Teva Pharmaceutical Industries formed in 1976 when Teva, Assia and Zori merged under Eli Hurvitz’s leadership.

Miriam Bernstein

Miriam Bernstein is the pen name of Hasbara’s Resources desk. Articles on this desk are written and published automatically by artificial intelligence, with no person reviewing them before publication.

Teva began with a Jerusalem wholesale medicine business founded in 1901 by pharmacists Chaim Salomon, Moshe Levin and Yitschak Elstein. That firm, Salomon, Levin and Elstein (S.L.E.), imported and distributed medicines; Teva Pharmaceutical Industries Ltd. took shape later, in a 1976 merger of Teva, Assia and Zori.

From imported medicines to Israeli production

S.L.E. was a distributor, not the company created in the later merger. Teva’s company history traces its beginnings to the three pharmacists and describes the growth of local pharmaceutical production in the following decades. Teva began trading on the Tel Aviv Stock Exchange in 1951 as Teva Middle East Pharmaceutical Chemical Works Company Ltd., a milestone recorded in Teva’s historical timeline.

During the 1930s, local drug production expanded as new pharmaceutical companies established manufacturing capacity. Teva’s historical account describes how local plants supplied the market during World War II, when imports were unavailable. The progression from distribution to local production helped establish the industrial base from which the later merged company grew.

What changed in 1976

In 1976, Teva, Assia and Zori consolidated as Teva Pharmaceutical Industries Ltd. Eli Hurvitz, who had joined Assia in 1953, initiated the consolidation and became chief executive of the new company. The Israel Democracy Institute biography of Eli Hurvitz recounts his Assia career and role in building Teva.

The merger joined three Israeli manufacturers; it was not a merger with S.L.E. Teva’s company history distinguishes its 1901 origins, 1951 listing and 1976 consolidation. In 1977, the merged company made its first move abroad by acquiring Dutch firm Orphahell. That early step began the international expansion described in Teva’s global growth under Hurvitz.

Sources

  1. 1.https://www.tevapharm.com/our-company/teva-history/
  2. 2.https://en.idi.org.il/hurvitz/2025/about-eli-hurvitz/

Accessibility

These settings are saved on this device.

Preview

Read clearly, your way

Adjust this page while you read. Explore resources

Text
Text sizeApplies across the site.
Colour and contrast
Theme
Motion
AnimationsMatch device follows your reduced motion setting.